• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过AAV6.2介导的片段反式剪接在囊性纤维化气道上皮细胞中实现功能性囊性纤维化跨膜传导调节因子表达。

Functional cystic fibrosis transmembrane conductance regulator expression in cystic fibrosis airway epithelial cells by AAV6.2-mediated segmental trans-splicing.

作者信息

Song Yuhu, Lou Howard H, Boyer Julie L, Limberis Maria P, Vandenberghe Luk H, Hackett Neil R, Leopold Philip L, Wilson James M, Crystal Ronald G

机构信息

Department of Genetic Medicine, Weill Cornell Medical College, New York, NY 10065, USA.

出版信息

Hum Gene Ther. 2009 Mar;20(3):267-81. doi: 10.1089/hum.2008.173.

DOI:10.1089/hum.2008.173
PMID:19257851
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2855253/
Abstract

Cystic fibrosis is characterized by deficiency of the cystic fibrosis transmembrane conductance regulator (CFTR), a Cl(-) transporter. The packaging constraints of adeno-associated viral (AAV) vectors preclude delivery of both an active promoter and CFTR cDNA to target cells. We hypothesized that segmental trans-splicing, in which two AAV vectors deliver the 5' and 3' halves of the CFTR cDNA, could mediate splicing of two pre-mRNAs into a full-length, functional CFTR mRNA. Using a segmental trans-splicing 5' donor-3' acceptor pair that split the CFTR cDNA between exons 14a and 14b, cotransfection of donor and acceptor plasmids into CFTR(-) cells resulted in full-length CFTR message and protein. Microinjection of plasmids into CFTR(-) cells produced cAMP-activated Cl(-) conductance. Vectors created with an engineered human serotype, AAV6.2, were used to deliver CFTR donor and acceptor constructs, resulting in full-length CFTR mRNA and protein as well as cAMP-activated Cl(-) conductance in CFTR(-) cells, including human CF airway epithelial IB3-1 cells. Thus, segmental trans-splicing can be used with AAV vectors to mediate expression of CFTR, a strategy potentially applicable to individuals with CF.

摘要

囊性纤维化的特征是囊性纤维化跨膜传导调节因子(CFTR)缺乏,CFTR是一种氯离子转运蛋白。腺相关病毒(AAV)载体的包装限制使得活性启动子和CFTR cDNA无法同时递送至靶细胞。我们推测,片段反式剪接(其中两个AAV载体分别递送CFTR cDNA的5'和3'半段)可将两个前体mRNA剪接成全长功能性CFTR mRNA。使用在第14a和14b外显子之间切割CFTR cDNA的片段反式剪接5'供体-3'受体对,将供体质粒和受体质粒共转染到CFTR(-)细胞中,可产生全长CFTR信息和蛋白质。将质粒显微注射到CFTR(-)细胞中可产生cAMP激活的氯离子传导。用工程化的人血清型AAV6.2构建的载体用于递送CFTR供体和受体构建体,在CFTR(-)细胞中产生全长CFTR mRNA和蛋白质以及cAMP激活的氯离子传导,包括人囊性纤维化气道上皮IB3-1细胞。因此,片段反式剪接可与AAV载体一起用于介导CFTR的表达,这一策略可能适用于囊性纤维化患者。

相似文献

1
Functional cystic fibrosis transmembrane conductance regulator expression in cystic fibrosis airway epithelial cells by AAV6.2-mediated segmental trans-splicing.通过AAV6.2介导的片段反式剪接在囊性纤维化气道上皮细胞中实现功能性囊性纤维化跨膜传导调节因子表达。
Hum Gene Ther. 2009 Mar;20(3):267-81. doi: 10.1089/hum.2008.173.
2
Spliceosome-mediated RNA trans-splicing with recombinant adeno-associated virus partially restores cystic fibrosis transmembrane conductance regulator function to polarized human cystic fibrosis airway epithelial cells.利用重组腺相关病毒进行的剪接体介导的RNA反式剪接可部分恢复囊性纤维化跨膜传导调节因子功能至极化的人囊性纤维化气道上皮细胞。
Hum Gene Ther. 2005 Sep;16(9):1116-23. doi: 10.1089/hum.2005.16.1116.
3
Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing.通过剪接体介导的RNA反式剪接对人类囊性纤维化气道上皮细胞中的内源性DeltaF508囊性纤维化跨膜传导调节因子进行部分校正。
Nat Biotechnol. 2002 Jan;20(1):47-52. doi: 10.1038/nbt0102-47.
4
Lack of correlation between CFTR expression, CFTR Cl- currents, amiloride-sensitive Na+ conductance, and cystic fibrosis phenotype.囊性纤维化跨膜传导调节因子(CFTR)表达、CFTR氯离子电流、氨氯地平敏感的钠离子电导与囊性纤维化表型之间缺乏相关性。
Pediatr Pulmonol. 1999 Apr;27(4):251-9. doi: 10.1002/(sici)1099-0496(199904)27:4<251::aid-ppul5>3.0.co;2-b.
5
[Post-translational ligation and function of dual-vector transferred split CFTR gene].[双载体转移的分裂型囊性纤维化跨膜传导调节因子基因的翻译后连接及功能]
Yao Xue Xue Bao. 2010 Jan;45(1):60-5.
6
Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.囊性纤维化气道中两个独立原发性缺陷的载体特异性互补图谱。
Hum Gene Ther. 1998 Mar 20;9(5):635-48. doi: 10.1089/hum.1998.9.5-635.
7
Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.囊性纤维化跨膜电导调节因子-mRNA 递呈:囊性纤维化基因治疗的新选择。
J Gene Med. 2013 Nov-Dec;15(11-12):414-26. doi: 10.1002/jgm.2748.
8
Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter.来自新型腺相关病毒启动子的囊性纤维化跨膜传导调节因子的表达
J Biol Chem. 1993 Feb 15;268(5):3781-90.
9
Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus.重复给予重组腺病毒后囊性纤维化患者气道上皮CFTR mRNA表达情况
J Clin Invest. 1999 Nov;104(9):1245-55. doi: 10.1172/JCI7935.
10
Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicing.通过剪接体介导的RNA反式剪接修复CFTR mRNA
Gene Ther. 2000 Nov;7(22):1885-95. doi: 10.1038/sj.gt.3301307.

引用本文的文献

1
Viral and nonviral nanocarriers for CRISPR-based gene editing.用于基于CRISPR的基因编辑的病毒和非病毒纳米载体。
Nano Res. 2024 Oct;17(10):8904-8925. doi: 10.1007/s12274-024-6748-5. Epub 2024 Jun 20.
2
Exploring AAV-Mediated Gene Therapy for Inner Ear Diseases: from Preclinical Success to Clinical Potential.探索腺相关病毒介导的内耳疾病基因治疗:从临床前成功到临床潜力
Adv Sci (Weinh). 2025 Sep;12(33):e08397. doi: 10.1002/advs.202408397. Epub 2025 Jun 20.
3
Engineering adeno-associated viral vectors for CRISPR/Cas based in vivo therapeutic genome editing.工程化腺相关病毒载体用于基于CRISPR/Cas的体内治疗性基因组编辑
Biomaterials. 2025 Oct;321:123314. doi: 10.1016/j.biomaterials.2025.123314. Epub 2025 Apr 2.
4
Current AAV-mediated gene therapy in sensorineural hearing loss.当前腺相关病毒介导的感音神经性听力损失基因治疗
Fundam Res. 2022 Sep 7;5(1):192-202. doi: 10.1016/j.fmre.2022.08.015. eCollection 2025 Jan.
5
A Manual for Genome and Transcriptome Engineering.《基因组与转录组工程手册》
IEEE Rev Biomed Eng. 2025;18:250-267. doi: 10.1109/RBME.2024.3494715. Epub 2025 Jan 28.
6
RNA exon editing: Splicing the way to treat human diseases.RNA外显子编辑:拼接治疗人类疾病的途径。
Mol Ther Nucleic Acids. 2024 Aug 16;35(3):102311. doi: 10.1016/j.omtn.2024.102311. eCollection 2024 Sep 10.
7
Adeno-associated virus as a delivery vector for gene therapy of human diseases.腺相关病毒作为人类疾病基因治疗的递送载体。
Signal Transduct Target Ther. 2024 Apr 3;9(1):78. doi: 10.1038/s41392-024-01780-w.
8
Advancements and future prospects of adeno-associated virus-mediated gene therapy for sensorineural hearing loss.腺相关病毒介导的感音神经性听力损失基因治疗的进展与未来前景
Front Neurosci. 2024 Jan 24;18:1272786. doi: 10.3389/fnins.2024.1272786. eCollection 2024.
9
Gene Therapy for Genetic Syndromes: Understanding the Current State to Guide Future Care.遗传综合征的基因治疗:了解当前状况以指导未来护理
BioTech (Basel). 2024 Jan 3;13(1):1. doi: 10.3390/biotech13010001.
10
Preclinical Efficacy And Safety Evaluation of AAV-OTOF in DFNB9 Mouse Model And Nonhuman Primate.AAV-OTOF 在 DFNB9 小鼠模型和非人灵长类动物中的临床前疗效和安全性评估。
Adv Sci (Weinh). 2024 Jan;11(3):e2306201. doi: 10.1002/advs.202306201. Epub 2023 Nov 28.

本文引用的文献

1
Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro.新型腺相关病毒载体在体内小鼠气道上皮和体外人纤毛气道上皮中的转导效率。
Mol Ther. 2009 Feb;17(2):294-301. doi: 10.1038/mt.2008.261. Epub 2008 Dec 9.
2
CFTR function and prospects for therapy.囊性纤维化跨膜传导调节因子的功能及治疗前景。
Annu Rev Biochem. 2008;77:701-26. doi: 10.1146/annurev.biochem.75.103004.142532.
3
Rapid/sustained anti-anthrax passive immunity mediated by co-administration of Ad/AAV.通过联合给予腺病毒(Ad)/腺相关病毒(AAV)介导的快速/持续抗炭疽被动免疫。
Mol Ther. 2008 Jan;16(1):203-9. doi: 10.1038/sj.mt.6300344. Epub 2007 Dec 4.
4
Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial.重复雾化腺相关病毒载体-囊性纤维化跨膜传导调节因子治疗囊性纤维化:一项随机安慰剂对照2B期试验
Hum Gene Ther. 2007 Aug;18(8):726-32. doi: 10.1089/hum.2007.022.
5
Expression of a truncated cystic fibrosis transmembrane conductance regulator with an AAV5-pseudotyped vector in primates.用AAV5假型载体在灵长类动物中表达截短的囊性纤维化跨膜传导调节因子
Mol Ther. 2007 Apr;15(4):756-63. doi: 10.1038/sj.mt.6300059. Epub 2007 Feb 13.
6
Efficient whole-body transduction with trans-splicing adeno-associated viral vectors.利用反式剪接腺相关病毒载体进行高效的全身转导。
Mol Ther. 2007 Apr;15(4):750-5. doi: 10.1038/sj.mt.6300081. Epub 2007 Jan 30.
7
Viral vector-mediated and cell-based therapies for treatment of cystic fibrosis.用于治疗囊性纤维化的病毒载体介导疗法和基于细胞的疗法。
Mol Ther. 2007 Feb;15(2):229-41. doi: 10.1038/sj.mt.6300002.
8
Hybrid adeno-associated virus bearing nonhomologous inverted terminal repeats enhances dual-vector reconstruction of minigenes in vivo.携带非同源反向末端重复序列的杂交腺相关病毒增强了体内小基因的双载体重建。
Hum Gene Ther. 2007 Jan;18(1):81-7. doi: 10.1089/hum.2006.128.
9
Synthetic intron improves transduction efficiency of trans-splicing adeno-associated viral vectors.合成内含子提高反式剪接腺相关病毒载体的转导效率。
Hum Gene Ther. 2006 Oct;17(10):1036-42. doi: 10.1089/hum.2006.17.1036.
10
Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered.9型腺相关病毒载体可转导小鼠肺泡和鼻上皮细胞,且可再次给药。
Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):12993-8. doi: 10.1073/pnas.0601433103. Epub 2006 Aug 22.